Related Experiment Video

Updated: Aug 14, 2026

Antagonistic Effect of Jiawei Shengjiang San on a Rat Model of Diabetic Nephropathy: Related to EGFR/MAPK3/1 Signaling Pathway
08:15

Antagonistic Effect of Jiawei Shengjiang San on a Rat Model of Diabetic Nephropathy: Related to EGFR/MAPK3/1 Signaling Pathway

Published on: May 10, 2024

[Effects of simvastatin on TGF-beta system of diabetic rat kidneys]

Zhuo-Xiong Chen1, Min-Xiang Lei, Li-Fang Zhu

  • 1Department of Endocrinology, Xiangya Hospital, Central South University, Changsha, China. Leimx@126.com

Zhong Nan Da Xue Xue Bao. Yi Xue Ban = Journal of Central South University. Medical Sciences
|December 3, 2005
PubMed
Abstract

Insights

Simvastatin offers renal protection in diabetic rats by reducing elevated levels of TGF-beta1 and Tbeta II R. This study reveals simvastatin

Area of Science:

  • Nephrology
  • Pharmacology
  • Diabetology

Context:

  • Diabetic nephropathy is a significant complication of diabetes mellitus.
  • The transforming growth factor-beta (TGF-beta) signaling pathway is implicated in diabetic kidney disease pathogenesis.
  • Statins, like simvastatin, are primarily known for their lipid-lowering effects but may possess other therapeutic properties.

Purpose:

  • To investigate the renoprotective effects of simvastatin in a rat model of diabetes.
  • To elucidate the underlying mechanism of simvastatin's renal benefit, focusing on the TGF-beta signaling pathway.

Summary:

  • Streptozotocin-induced diabetic rats were treated with simvastatin.
  • Kidney tissues were analyzed for the expression of TGF-beta1 and its receptor (Tbeta II R) using immunohistochemistry, RT-PCR, and Western blot.
  • Simvastatin treatment significantly decreased the elevated mRNA and protein levels of TGF-beta1 and Tbeta II R in diabetic rat kidneys compared to untreated diabetic rats.

Impact:

  • Simvastatin demonstrates a protective role in diabetic kidneys.
  • The findings suggest that simvastatin exerts its renoprotective effects by down-regulating TGF-beta1 and Tbeta II R, thereby inhibiting the TGF-beta signaling pathway.
  • This study provides a potential therapeutic strategy for managing diabetic kidney disease.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...